Startups
Insud Pharma opera en toda la cadena de valor de la industria farmacéutica con soluciones innovadoras en investigación, desarrollo, fabricación y comercialización de APIs, FDFs y biofármacos. Ofrecemos productos de alta calidad para el cuidado humano y animal en diversas áreas terapéuticas.
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 9, 2024 | mAbxience Appoints Jurgen Van Broeck as New CEO | MADRID, May 9, 2024 /PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, is pleased to announce the appointment of Jurgen Van Broeck as Chief Executive Officer. Jurgen, who has served as... |
| Mar 13, 2024 | Rovi, Insud Pharma y CDTI Innovación crean la primera empresa de terapias avanzadas, movilizando más de €74M | 13/03/2024 Nota de prensa ROVI, INSUD PHARMA Y CDTI INNOVACIÓN CREAN LA PRIMERA EMPRESA DE TERAPIAS AVANZADAS, MOVILIZANDO MÁS DE €74M El Consejo de Ministros ha aprobado hoy la creación de la primera sociedad mercantil de terapias avanzada... |
| Aug 29, 2022 | Zerion Pharma and Insud Pharma announce collaboration to develop Dispersome® formulations of marketed drug products | Zerion Pharma and Insud Pharma announce collaboration to develop Dispersome® formulations of marketed drug products Mon, Aug 29, 2022 12:00 CET Report this content - The two companies have started collaborating on the first two drug product... |
Reviews 0
FAQ about Insud Pharma
What has the press written about Insud Pharma?
Parsers VC has collected 4 articles mentioning Insud Pharma, among them “mAbxience Appoints Jurgen Van Broeck as New CEO” (May 9, 2024) and “Rovi, Insud Pharma y CDTI Innovación crean la primera empresa de terapias avanzadas, movilizando más de €74M” (Mar 13, 2024).
Is Insud Pharma still active?
Yes, Insud Pharma is active; its latest activity on Parsers VC dates from May 30, 2024.